Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, net loss was USD 0.405061 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9401 USD | -5.04% | -16.81% | -91.45% |
1st Jan change | Capi. | |
---|---|---|
-91.45% | 14.58M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |